News
CAR T Cells Drive Recovery in Severe Autoimmune Disease Case
2+ hour, 13+ min ago (351+ words) A single infusion of zorpocabt agene-autoleucel (Zorpo-cel), an autologous CAR T-cell therapy, has led to a rapid and sustained remission in a patient with multiple life-threatening autoimmune disorders, according to a newly reported case published in Med." The patient's condition…...
Moving In Vivo: Next Steps For CAR T-Cell Therapy
20+ hour, 31+ min ago (1802+ words) There is no doubt that autologous chimeric antigen receptor (CAR) T-cell therapy has revolutionized the treatment of serious blood cancers. A significant proportion of advanced-stage blood cancer patients who failed to respond to previous therapies now go into remission with…...
Smart Contact Lens Offers Glaucoma Treatment Potential
23+ hour, 13+ min ago (349+ words) A "smart contact lens" can monitor eye pressure and manage and release glaucoma drugs to counteract any rises in this, preclinical research suggests. The battery-free device was able to monitor intraocular pressure'the most prominent, modifiable risk factor for glaucoma'and could…...
Bladder Cancer: Urine Test Improves Relapse Predictions
22+ hour, 39+ min ago (506+ words) Stanford researchers have developed a urine test that can accurately predict which patients with bladder cancer will respond to standard surgery and immunotherapy treatments. In a study published in Cell, they report that this DNA test takes into account background…...
Smart MRI Agents Combine Cancer Imaging and Therapy in Single Platform
23+ hour, 15+ min ago (245+ words) Our goal was to create materials that allow doctors to see cancer clearly and treat it at the same time," said lead author Farah Benyettou, Ph D, a research scientist at NYU Abu Dhabi. The ability to image and target…...
23and Me Reports Genetic Predictors of Response to GLP-1 Drugs for Obesity
23+ hour, 8+ min ago (996+ words) Adam Auton, Ph D, 23and Me's VP of Human Genetics, explains how the company's SNP database and a questionnaire found efficacy and side-effect variants By Jonathan D. Grinstein, Ph D But there are some major problems, one being that these'drugs'don't'work uniformly. Some…...
Lung Screening Incidental Findings May Guide Follow-Up for Other Cancers
1+ day, 1+ hour ago (542+ words) An analysis of the US National Lung Screening Trial (NLST) has found that the presence of certain types of abnormalities in regions outside of the lungs on low-dose computed tomography (LDCT) images may be associated with a significantly increased risk…...
Base Editing Shows Early Promise for Treating Beta Thalassemia
1+ day, 2+ hour ago (560+ words) The Chinese biotech Correct Sequence Therapeutics, also known as Correctseq, reports good results from a Phase I study of its technology involving editing a person's hematopoietic stem cells to treat beta thalassemia. The trial, published in Nature, included five patients…...
From Reactive to Proactive: Reimagining Hypertension Management in the Precision Medicine Era
1+ day, 19+ hour ago (1512+ words) According to the World Health Organization, an estimated 1. 4billion adults aged 3079worldwide had hypertension in 2024, representing around one-third of the global population of that age. Of these, 44% were unaware that they were living with a leading risk factor for premature death and…...
The Digital Path to AI in Cancer Care
1+ day, 21+ hour ago (838+ words) As such, a foundation model provides a reusable digitized computational backbone that can be tapped across a wide range of uses, like tumor classification, detection of morphologic structures, biomarker quantification, and outcome prediction. In short, foundational models make the process…...